Home Markets Contineum Therapeutics stock falls on phase 2 trial miss

Contineum Therapeutics stock falls on phase 2 trial miss

Sep 14, 2026 comments off

Original source: https://www.investing.com/news/stock-market-news/contineum-therapeutics-stock-falls-on-phase-2-trial-miss-93CH-4900355

You May Also Like

US aims to issue deep-sea mining permits within months, Interior Secretary Burgum says

Experts urge FDA to set clear safety and access standards for psychedelic drugs

U.S. stock futures flat as markets parse slowing AI development, Fed anticipation

U.S. stocks end well off session lows as oil pares gains, countering slide in tech

Enova stock falls after dropping Grasshopper acquisition bid

Abbott to pay $384 million over contaminated infant formula allegations, US Justice Dept says